Noninvasive Neuromodulation to Reserve Diastolic Dysfunction (NERDD)
Primary Purpose
Heart Failure, Diastolic
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
transcutaneous vagus nerve stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Heart Failure, Diastolic
Eligibility Criteria
Inclusion Criteria:
- Male and female patients older than 18 year old
- Evidence of diastolic dysfunction on echocardiogram within 24 months of study enrollment
Exclusion Criteria:
- Left ventricular dysfunction (Left ventricular ejection fraction <40%)
- Significant valvular disorder (i.e., prosthetic valve or hemodynamically relevant valvular diseases)
- Recent (<6 months) stroke or myocardial infarction
- Severe heart failure (NYHA class III or IV)
- Recurrent vaso-vagal syncopal episodes
- Unilateral or bilateral vagotomy
- Pregnancy or breast feeding
- Sick sinus syndrome (without a pacemaker), 2nd or 3rd degree AV block, bifascicular block or prolonged (PR>300ms) 1st degree AV block
Sites / Locations
- University of Oklahoma Health Sciences Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
Sham stimulation first
Active stimulation first
Arm Description
Sham stimulation delivered at the earlobe (devoid of vagal innervation) is given on first session. Transcutaneous vagus nerve stimulation delivered at the tragus (vagal innervation) is given on second session.
Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session. Sham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.
Outcomes
Primary Outcome Measures
Echocardiographic Markers of Diastolic Dysfunction
Global longitudinal strain
Secondary Outcome Measures
Heart Rate Variability Measures
low frequency to high frequency ratio. This is a measure of sympathovagal balance. A lower value reflects a more favorable balance between sympathetic and parasympathetic (vagal) tone.
Full Information
NCT ID
NCT02983448
First Posted
November 30, 2016
Last Updated
June 13, 2019
Sponsor
University of Oklahoma
1. Study Identification
Unique Protocol Identification Number
NCT02983448
Brief Title
Noninvasive Neuromodulation to Reserve Diastolic Dysfunction
Acronym
NERDD
Official Title
Noninvasive Neuromodulation to Reserve Diastolic Dysfunction
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
December 2016 (Actual)
Primary Completion Date
March 2018 (Actual)
Study Completion Date
April 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Oklahoma
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a 2x2 cross over pilot study using low level transcutaneous vagus nerve stimulation (LLTS) to reverse diastolic dysfunction in patients with diastolic dysfunction. All patients will receive 2 separate, 1-hour sequences, at least 1 day apart, of active and sham LLTS, but the sequence will be randomized. Patients will be randomly assigned (1:1) to active/sham or sham/active LLTS. LLTS will be performed using a transcutaneous electrical nerve stimulation (TENS) device with electrodes attached to the tragus of the ear, which is innervated by auricular branch of the vagus nerve. Echocardiography will be performed after 30 minutes of LLTS or sham stimulation to assess diastolic function. Five-minute ECGs will be obtained for HRV analysis every 15 minutes of stimulation (total of 4 recordings).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Diastolic
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sham stimulation first
Arm Type
Placebo Comparator
Arm Description
Sham stimulation delivered at the earlobe (devoid of vagal innervation) is given on first session.
Transcutaneous vagus nerve stimulation delivered at the tragus (vagal innervation) is given on second session.
Arm Title
Active stimulation first
Arm Type
Active Comparator
Arm Description
Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session.
Sham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.
Intervention Type
Device
Intervention Name(s)
transcutaneous vagus nerve stimulation
Intervention Description
All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized
Primary Outcome Measure Information:
Title
Echocardiographic Markers of Diastolic Dysfunction
Description
Global longitudinal strain
Time Frame
after 1 hour of stimulation
Secondary Outcome Measure Information:
Title
Heart Rate Variability Measures
Description
low frequency to high frequency ratio. This is a measure of sympathovagal balance. A lower value reflects a more favorable balance between sympathetic and parasympathetic (vagal) tone.
Time Frame
after 1 hour of stimulation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male and female patients older than 18 year old
Evidence of diastolic dysfunction on echocardiogram within 24 months of study enrollment
Exclusion Criteria:
Left ventricular dysfunction (Left ventricular ejection fraction <40%)
Significant valvular disorder (i.e., prosthetic valve or hemodynamically relevant valvular diseases)
Recent (<6 months) stroke or myocardial infarction
Severe heart failure (NYHA class III or IV)
Recurrent vaso-vagal syncopal episodes
Unilateral or bilateral vagotomy
Pregnancy or breast feeding
Sick sinus syndrome (without a pacemaker), 2nd or 3rd degree AV block, bifascicular block or prolonged (PR>300ms) 1st degree AV block
Facility Information:
Facility Name
University of Oklahoma Health Sciences Center
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
30560316
Citation
Tran N, Asad Z, Elkholey K, Scherlag BJ, Po SS, Stavrakis S. Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans. J Cardiovasc Transl Res. 2019 Jun;12(3):221-230. doi: 10.1007/s12265-018-9853-6. Epub 2018 Dec 17.
Results Reference
derived
Learn more about this trial
Noninvasive Neuromodulation to Reserve Diastolic Dysfunction
We'll reach out to this number within 24 hrs